Yikon Genomics
PrivateLast Round
Series D
May 6, 2021
Total Funding Raised
$95.42M
Company Overview
Yikon Genomics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in May 2021.
Yikon Genomics is a biotechnology company that provides single-cell sequencing services and products for reproductive health and cancer diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yikon Genomics Comparables
Compare Yikon Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Basecare | 83% | |
| Progenesis | 82% | |
| Juno Genetics | 80% |
For institutional investors. Book with your work email.
Yikon Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 6, 2021 | ||||
| Strategic | Oct 1, 2020 | ||||
| Series C | Nov 5, 2019 | ||||
| Series B | Sep 1, 2016 | ||||
| Series A | Aug 1, 2015 |
For institutional investors. Book with your work email.
Yikon Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCIC Capital | Strategic |
| Oriza Holdings | Series D |
| 健壹资本 | Series D |
| BOCOM International Holdings Company Limited | Series C |
| 6 Dimensions Capital | Series A |
| Yunfeng Capital | Series D |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
Grew 17% QoQ, from 35 to 41 employees.
- Sep 3, 2023
Grew 36% QoQ, from 22 to 30 employees.
For institutional investors. Book with your work email.
Yikon Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Yikon Genomics's valuation, stock price, and market status.
Is Yikon Genomics a public or private company?
Yikon Genomics is a private company.
What is the current stock price of Yikon Genomics?
Yikon Genomics is a private company, so its shares have no public market price. Caplight tracks Yikon Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yikon Genomics worth (valuation)?
Valuation information for Yikon Genomics is not publicly available.
Can I buy Yikon Genomics stock?
Yikon Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yikon Genomics's last funding round?
Yikon Genomics's most recent funding round was Series D on May 6, 2021.
Who are the main investors in Yikon Genomics?
Key investors in Yikon Genomics include CCIC Capital, Oriza Holdings, 健壹资本, BOCOM International Holdings Company Limited, 6 Dimensions Capital.
Will Yikon Genomics IPO soon?
No public IPO plans have been announced for Yikon Genomics.
How can I track Yikon Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Yikon Genomics's shares on secondary markets.